Pulse Biosciences (PLSE) Current Leases (2019 - 2026)

Pulse Biosciences has reported Current Leases for 8 years, with the latest figure at $1.7 million in Q2 2026.

• On a quarterly basis, Current Leases rose 15.56% year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $1.7 million, a 15.56% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 15.87% from the prior year.
• Current Leases was $1.7 million for Q2 2026 at Pulse Biosciences, up from $1.6 million in the prior quarter.
• The five-year high for Current Leases was $1.7 million in Q2 2026, with the low at $799000.0 in Q1 2022.
• Average Current Leases over 5 years is $1.2 million, with a median of $1.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Current Leases dropped 15.31% in 2022, then climbed 28.07% in 2024.
• Over 5 years, Current Leases stood at $896000.0 in 2022, then climbed by 18.08% to $1.1 million in 2023, then increased by 28.07% to $1.4 million in 2024, then gained by 15.87% to $1.6 million in 2025, then increased by 7.39% to $1.7 million in 2026.
• The last three Current Leases figures came in at $1.7 million (Q2 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.